6-39909055-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM2PM5PP3
The ENST00000373188.6(MOCS1):c.1150G>A(p.Gly384Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,610,870 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G384V) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000373188.6 missense
Scores
Clinical Significance
Conservation
Publications
- sulfite oxidase deficiency due to molybdenum cofactor deficiency type AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MOCS1 | NM_001358530.2 | c.1150G>A | p.Glu384Lys | missense_variant, splice_region_variant | Exon 10 of 11 | ENST00000340692.10 | NP_001345459.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000134 AC: 2AN: 149486Hom.: 0 Cov.: 29 show subpopulations
GnomAD4 exome AF: 0.0000198 AC: 29AN: 1461384Hom.: 0 Cov.: 31 AF XY: 0.0000261 AC XY: 19AN XY: 727014 show subpopulations
GnomAD4 genome AF: 0.0000134 AC: 2AN: 149486Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 72722 show subpopulations
ClinVar
Submissions by phenotype
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A Pathogenic:1Uncertain:4
- -
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 384 of the MOCS1 protein (p.Gly384Ser). This variant is present in population databases (rs751603831, gnomAD 0.007%). This missense change has been observed in individual(s) with molybdenum cofactor deficiency (PMID: 9921896). ClinVar contains an entry for this variant (Variation ID: 534542). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change affects MOCS1 function (PMID: 11891227). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
- -
The missense variant in c.1150G>A(p.Glu384Lys) in MOCS1 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Glu384Lys variant is novel (not in any individuals) in gnomAD Exomes and 1000 Genomes and has an allele frequency of 0.003203% from gnomAD database. This variant has been reported to the ClinVar database as Uncertain Significance (VUS). The amino acid change p.Glu384Lys in MOCS1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Glu at position 384 is changed to a Lys changing protein sequence and it might alter its composition and physico-chemical properties. For these reasons, this variant has been classified as Variant of Uncertain Significance (VUS). The above variant has been observed in the spouse. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at